MNKD NASDAQ
Credit Risk of going bust: higher than 77% of companies Debt: 23.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.13 (down 96%), MannKind Corporation would be worth roughly what it owes.
Total debt $330.8M against a stock market value of $1.06B.
Distance to default 2.85 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $159.5M (short-term plus half of long-term), stock volatility 74.5%; Altman Z'' -13.46. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Danbury, CA 06810
US
MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Binder Steven B. | S-Sale | 39,051 | $3.29 | 2026-09-25 |
| Binder Steven B. | S-Sale | 33,558 | $3.81 | 2026-09-10 |
| Binder Steven B. | S-Sale | 39,051 | $4.06 | 2026-08-07 |
| Thomson David | S-Sale | 24,109 | $4.05 | 2026-07-17 |
| Binder Steven B. | S-Sale | 52,485 | $4.06 | 2026-07-17 |